Table 3 Comparison of treatment regimens for COVID-19 and CAP before and after propensity matching
Characteristics | Unmatched | Matched | ||||
|---|---|---|---|---|---|---|
CAP, N = 119 | COVID-19, N = 70 | p-value | CAP, N = 37 | COVID-19, N = 37 | p-value | |
Use of ventilators | 0.005 | 0.80 | ||||
Yes | 98 (82%) | 45 (64%) | 27 (73%) | 26 (70%) | ||
No | 21 (18%) | 25 (36%) | 10 (27%) | 11 (30%) | ||
Antimicrobial | 0.027 | 0.24 | ||||
Yes | 118 (99%) | 65 (93%) | 37 (100%) | 34 (92%) | ||
No | 1 (0.8%) | 5 (7.1%) | 0 (0%) | 3 (8%) | ||
Antiviral therapy | < 0.001 | 0.003 | ||||
Yes | 13 (11%) | 28 (40%) | 4 (11%) | 15 (41%) | ||
No | 106 (89%) | 42 (60%) | 33 (89%) | 22 (59%) | ||
γ-globulin | < 0.001 | 0.011 | ||||
Yes | 2 (1.7%) | 13 (19%) | 0 (0%) | 7 (19%) | ||
No | 117 (98%) | 57 (81%) | 37 (100%) | 30 (81%) | ||
Prone position ventilation | < 0.001 | < 0.001 | ||||
Yes | 0 (0%) | 21 (30%) | 0 (0%) | 10 (27%) | ||
No | 119 (100%) | 49 (70%) | 37 (100%) | 27 (73%) | ||
Glucocorticosteroid | 0.24 | 0.64 | ||||
Yes | 49 (41%) | 35 (50%) | 16 (43%) | 14 (38%) | ||
No | 70 (59%) | 35 (50%) | 21 (57%) | 23(62%) | ||
Fluid resuscitation | 0.057 | 0.62 | ||||
Yes | 43 (36%) | 16 (23%) | 13 (35%) | 11 (30%) | ||
No | 76 (64%) | 54 (77%) | 24 (65%) | 26 (70%) | ||
Continuous renal replacement therapy | 0.59 | >0.99 | ||||
Yes | 15 (13%) | 7 (10%) | 5 (14%) | 4 (11%) | ||
No | 104 (87%) | 63 (90%) | 32 (86%) | 33 (89%) | ||
Anticoagulation | 0.79 | 0.16 | ||||
Yes | 52 (44%) | 32 (46%) | 18 (49%) | 12 (32%) | ||
No | 67 (56%) | 38 (54%) | 19 (51%) | 25 (68%) | ||
Vasopressors | 0.27 | 0.24 | ||||
Yes | 76 (64%) | 39 (56%) | 18 (49%) | 23 (62%) | ||
No | 43 (36%) | 31 (44%) | 19 (51%) | 14 (38%) | ||